文传商讯

Rimini Street to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28, 2024
2024-02-19 18:41:20

Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonis
2024-02-19 18:41:20